Universe Pharmaceuticals INC (UPC) stock

UPCNasdaqPharmaceutical PreparationsFiscal year ends September 30

Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jan 29, 2026Score 5/30

$1.51−0.02 (-1.31%)

Close on Nov 13, 2026Market cap $850.64KP/E –Yield –

Universe Pharmaceuticals EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Universe Pharmaceuticals's EV/EBITDA was 0.6× on Apr 29, 2022, against 4.8× a year earlier.

Period	Period end	Value	Change (pts)
2022	Apr 29, 2022	0.6×	−0.7
2021	Dec 31, 2021	1.3×	–

Parsed from the XBRL in Universe Pharmaceuticals's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-600 reverse split on Apr 29, 2025
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing